-

Wiley and FinELib Sign Transitional Agreement Continuing Expansion in Open Access

HOBOKEN, N.J.--(BUSINESS WIRE)--John Wiley & Sons, Inc. (NYSE: JWA) (NYSE: JWB), a global leader in research and education, and FinELib, a Finnish consortium of higher education and research institutions, have announced a new three-year license that combines an open access and subscription agreement effective February 2020. This 3-year agreement will provide 22 Finnish institutions with continued access to Wiley’s subscription journals and enables their affiliated authors to publish open access articles in Wiley’s fully gold and hybrid journals.

“FinELib is pleased to announce an agreement with Wiley offering open access publishing options for our researchers. With this agreement the amount of open access articles will increase substantially,” stated Arja Tuuliniemi, head of licensing at FinELib.

“We are very pleased to partner with FinELib to advance the open access landscape in Finland. This is an exciting continuation down the path to an open research future,” said Judy Verses, Wiley’s executive vice president, Research.

As part of the agreement, eligible researchers and students will be automatically identified and notified of the opportunity to publish open access through their institutional connection, at no additional charge. FinELib institutions will continue to have access to all of Wiley’s journal content. The 22 eligible institutions will also have access to a distinct open access account dashboard for easy administration of their account, quick article approval, and reporting.

Additional Information

About FinELib

FinELib is a consortium of Finnish higher education institutions, research institutions and public libraries. Its mission is to secure and improve the availability of electronic resources. FinELib promotes openness by negotiating transformative agreements in order to make a transition to open access, without additional costs for the scholarly community. More information at: http://finelib.fi/negotiations/.

About Wiley

Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at www.wiley.com.

Contacts

Wiley:
Brian Campbell (US): +1 201-748-6874
Investor Relations
Brian.campbell@wiley.com

Dawn Peters (US): +1 781-388-8408
Corporate Communications & Global Media Relations
newsroom@wiley.com
Follow us on Twitter @WileyNews

FinELib:
Arja Tuuliniemi: +358505706584
Head of Licensing, FinELib
arja.tuuliniemi@helsinki.fi

Toni Vesterinen: +358503183421
Licensing Coordinator, FinELib
toni.vesterinen@helsinki.fi
Twitter: @FinELibpalvelu

John Wiley & Sons, Inc.

NYSE:WLY
Details
Headquarters: Hoboken, New Jersey
CEO: Matthew Kissner
Employees: 7,000
Organization: PUB

Release Versions

Contacts

Wiley:
Brian Campbell (US): +1 201-748-6874
Investor Relations
Brian.campbell@wiley.com

Dawn Peters (US): +1 781-388-8408
Corporate Communications & Global Media Relations
newsroom@wiley.com
Follow us on Twitter @WileyNews

FinELib:
Arja Tuuliniemi: +358505706584
Head of Licensing, FinELib
arja.tuuliniemi@helsinki.fi

Toni Vesterinen: +358503183421
Licensing Coordinator, FinELib
toni.vesterinen@helsinki.fi
Twitter: @FinELibpalvelu

More News From John Wiley & Sons, Inc.

Wiley and IQVIA Release Cross-Sector Report on AI’s Promise and Pressure Points Across Healthcare Value Chain

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY) and IQVIA (NYSE: IQV) today released Scientific Discovery & AI: The Science-to-Patient Journey, a cross-sector intelligence report drawing on candid dialogue among more than 25 senior leaders from pharma R&D, academic medicine, health systems, AI and technology, publishing and learned societies. The report summarizes insights from The Summit — an invitation-only, two-day working session co-hosted by Wiley and IQVIA in May 2026. The sessi...

Wiley Acquires Emerald, Expanding Research Scale and Deepening Proprietary Content Across the AI-Driven Knowledge Economy

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY) today announced it has acquired Emerald Publishing Limited in an all-cash transaction valued at £337 million, or USD 452 million....

Wiley Equips the World’s Laboratories with Intelligence to Identify Substances Faster and Decide with Confidence

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation and learning, today released the Wiley Registry of Mass Spectral Data 2026. As AI-driven research pipelines become standard practice across pharmaceuticals, materials science and forensic investigation, the quality of reference data underpinning those pipelines determines whether results are trusted—or stall at the verifica...
Back to Newsroom